Fellos raises €4.2 million, with €3 million coming from the Dutch Dragons
Mila Health, the parent company of Fellos, has successfully closed a €4.2 million funding round. Through Dutch Dragons, €3 million was raised in just two days. Driven by rapid patient growth—from 10,000 to over 30,000 patients—Fellos will use this capital to fuel European expansion, strengthen its medical team, and broaden its online men's health services into new medical domains.
Fellos raises €4.2 million, with €3 million from the Dutch Dragons
Amsterdam, 5 August 2026
Healthcare technology company Mila Health, the parent company behind the consumer brands Fellos and Goodweigh, has raised €4.2 million in a funding round. Of this, €3 million comes from the Dutch Dragons, who announced the round during their podcast. Mila Health will use the capital to accelerate the development of its digital healthcare platform and its expansion across Europe.
Two years ago, founders Sibren Tolsma and Rob Smeitink set out with a single idea: to give people more control over their own health by making high-quality care simpler and more accessible. Mila Health has now helped over 30,000 patients through Fellos and Goodweigh, has more than 40 healthcare providers working on the treatments, and operates in the Netherlands, Germany, Denmark and Sweden.
A growth curve that even surprised the Dragons
Growth was much faster than initially anticipated. Whereas Mila Health was helping around 10,000 patients a year ago, the figure now stands at over 30,000. During the same period, the company expanded from the Netherlands into four European markets and its healthcare team grew to more than 40 healthcare professionals. Behind the investment are Dutch Dragons Bas Witvoet, Pieter Schoen and Michel Perridon.
“I’ve seen hundreds, if not over a thousand, business plans come my way. I always say: everything works out in Excel. Last year, you presented a fantastic Excel spreadsheet and said it would triple. It didn’t triple – it multiplied by twelve.” — Pieter Schoen, Dutch Dragons
The Dragons aren’t investing solely for financial reasons. “As well as generating a good return, you’re investing in good healthcare. And I think that’s just as important,” says the investor.
Care as the core, not an afterthought
Mila Health deliberately focuses on conditions that lend themselves well to fully online care. Patients start by completing a medical intake form, drawn up in consultation with doctors and pharmacists, after which their identity is verified and a doctor assesses and supervises their treatment.
“People increasingly want to take control of their own health. That’s what we enable them to do at Goodweigh and Fellos: high-quality, doctor-led care, but made accessible and with guidance at every step.” — Rob Smeitink, co-founder of Mila Health
It is precisely this guidance that sets the platform apart from the illegal or unregulated channels from which many people currently source their medication, with all the associated health risks.
What Mila Health plans to do with the funding
With this investment, Mila Health is accelerating the technical development of its healthcare platform. A significant portion of the capital will go towards improving the digital infrastructure. In addition, Goodweigh and Fellos are expanding their services into new areas of care, such as transitional care, and continuing their growth across Europe. The quality of care remains the guiding principle behind this acceleration. Mila Health is making a deliberate investment in ensuring its care team and support services grow in line with patient numbers, so that even as the organisation scales up rapidly, careful medical supervision and personal contact remain paramount.
Funding round fully subscribed within two days
There was considerable interest in the funding round. Dutch Dragons invested €300,000 themselves and made the remaining portion of the €3 million available to other investors via their own funding platform. The Dragons indicated that they would prefer to fund the round entirely themselves, and undertook to cover at least the portion not filled by investors. This proved unnecessary: the full €3 million was raised within two days.
“This is the largest funding round realised via Dutch Dragons to date. Reportedly, it even sets a Dutch record for the fastest-raised investment of this size.” — Pieter Schoen, Dutch Dragons
The fact that the amount was raised so quickly is a sign of the confidence investors have in both Mila Health’s growth story and its social value.
We’re continuing to grow rapidly and are looking for people
Mila Health is continuing to grow rapidly and currently has seven vacancies. Would you like to help make healthcare more accessible across Europe? We’d love to hear from you. Check our website for the vacancies.
About Mila Health
Mila Health is a Dutch digital healthcare provider, founded by Rob Smeitink and Sibren Tolsma. The company builds digital healthcare brands that combine medical expertise, technology and a user-friendly patient journey, with the aim of making high-quality care more accessible and personalised. To date, Mila Health has helped over 30,000 patients, employs more than 40 healthcare professionals to deliver treatments, and operates in the Netherlands, Germany, Denmark and Sweden. Mila Health’s portfolio includes:
- Fellos: online healthcare for men, offering treatments for conditions such as erectile dysfunction, hair loss and testosterone assessment and management.
- Goodweigh: medically supervised weight loss.
Further information: https://www.milahealth.co
About Dutch Dragons
Dutch Dragons brings together entrepreneurship, investment and media. On the Dutch Dragons podcast, entrepreneurs and investors Bas Witvoet, Pieter Schoen and Michel Perridon speak with founders about their companies, growth and ambitions. The Dragons invest in selected ventures themselves, whilst other investors are given the opportunity to co-invest via dutchdragons.nl. The Dutch Dragons funding platform is facilitated by Eyevestor.
Further information: https://www.dutchdragons.nl
Fellos adheres to strict editorial guidelines for sources to ensure the accuracy and timeliness of our content. Our content is based on scientific publications, research from academic institutions, and reputable medical organizations. If you notice an error, please let us know at [email protected].
This article is for informational purposes only and does not constitute medical advice. The information herein is not a substitute for professional medical advice and should never be relied upon. Always discuss the risks and benefits of any treatment with your doctor.
This content was last updated on
6/8/2026

Looking for treatment?
Complete the online questionnaire in just 3 minutes and our doctors will work with you to determine the most appropriate treatment.
No queues, no awkward conversations. 100% online and free from embarrassment or taboos.


.svg.png)